The “Dolo case” appears as a small manifestation of a much larger problem, underlining the urgent need for a comprehensive and effective regulation of the pharmaceutical industry and private healthcare sector in public interest.
- October 1, 2022
- Posted by: OptimizeIAS Team
- Category: DPS Topics
No Comments